Chart Synthorx, Inc.

Duration

Period

Style

Latest news about Synthorx, Inc.

Synthorx, Inc.(NasdaqGS:THOR) dropped from S&P Global BMI Index	24/20/24	CI
Synthorx, Inc.(NasdaqGM:THOR) dropped from S&P TMI Index	24/20/24	CI
Synthorx, Inc. Announces Executive Changes	24/20/24	CI
Synthorx, Inc.(NasdaqGS:THOR) dropped from NASDAQ Composite Index	23/20/23	CI
Sanofi completed the acquisition of Synthorx, Inc. from Avalon Ventures, LLC, Correlation Ventures, OrbiMed Advisors LLC, Medicxi Ventures (UK) LLP and others.	23/20/23	CI
Tesla gets Chinese boost, Boeing’s new troubles, scandal for Tesco…	23/19/23
Synthorx : Sanofi shares rally on new margin goals, narrower drug focus	10/19/10	RE
Synthorx : Sanofi ends research in diabetes, narrows units to spur profit	10/19/10	RE
European shares dragged down by Tullow Oil and weak China export data	09/19/09	RE
Synthorx : France's Sanofi to buy biotech firm Synthorx for $2.5 billion	09/19/09	RE
Synthorx : France's Sanofi to buy biotech firm Synthorx for $2.5 billion	09/19/09	RE
Sanofi entered into definitive agreement to acquire Synthorx, Inc. from Avalon Ventures, LLC, Correlation Ventures, OrbiMed Advisors LLC, Medicxi Ventures (UK) LLP and others for $2.2 billion.	09/19/09	CI
Synthorx, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	06/19/06	CI
Synthorx, Inc. to Present THOR-809 Data at the American College of Rheumatology Annual Meeting	05/19/05	CI
Synthorx to Present At the European Society for Medical Oncology 2019 Congress	23/19/23	CI

SYNTHORX, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/20/24	AQ
Sanofi : - Hart-Scott-Rodino waiting period expires for Sanofi :'s acquisition of Synthorx	21/20/21	AQ
WeissLaw LLP Investigates Synthorx, Inc.	13/19/13	PR
Sanofi : to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion	10/19/10	AQ
Synthorx : Drug giant Sanofi to buy U.S. biotech firm Synthorx for $2.5B	09/19/09	AQ

La mauvaise semaine des bourses européennes	24/20/24
EN DIRECT DES MARCHES : Carrefour, Ipsen, Rémy Cointreau, Engie, Altice Europe, Orange, Bayer...	24/20/24
Une semaine chargée en perspective	20/20/20
EN DIRECT DES MARCHES : Sanofi, Iliad, Casino, Airbus, Total, Marie Brizard, Imerys, Boeing, Tesla...	20/20/20
EN DIRECT DES MARCHES : Sanofi, Renault, Virbac, Marie Brizard, Recylex, Crédit Suisse, Tencent...	23/19/23